Senate Health Bill Would Bring Drug Price Controls
By Peter R. OrszagThe author says states would put tight new limits on the drugs their Medicaid plans cover.
June 28, 2017
Beauty Is in the Eye of the Discloser: Suggestions for CFP Board’s New StandardsWhile most reviewers are applauding the proposals, one point that astute observers make is that they take a rather soft stand on conflicts of interest.
June 28, 2017
SEC Cyber Enforcement Likely to Make Advisors, BDs WannaCryEnforcement actions for failures to protect against cyber threats appear to be an issue everyone at the SEC can get behind.
June 28, 2017
Lloyd's of London Is Not Just for Celebrity Body PartsClients' needs come in different sizes. Sometimes, the advisor may want to recommend a trip to the tailor.
June 27, 2017
Senate's Health Bill's Pain Doesn't End at MedicaidThe author thinks BCRA could lead low-income people to pay high prices for awful coverage.
June 27, 2017
Open Architecture Is Key for RIA/BD HybridsFor hybrid firms, its important to do things in as efficient and cost-effective a manner as possible.
June 27, 2017
Not All Active Managers Are Poor PerformersIts more important now than ever to understand how to distinguish truly active, high-performing funds from low-performing closet indexers.
June 27, 2017
Tactical Investing Tips Advisors Can Use NowThese tools can help advisors express opinions on short-term market movements for opportunistic alpha, or profit from broad-based sector declines in the longer term.
Commentary